Health · 1 sources covering this

New study supports testing of Merck’s Ebola vaccine in DRC outbreak

New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
New study supports testing of Merck’s Ebola vaccine in DRC outbreak
New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/a37536beb1de22ca6bbbffecc03f53df609e395c"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="New study supports testing of Merck’s Ebola vaccine in DRC outbreak"></iframe>

New study supports testing of Merck’s Ebola vaccine in DRC outbreak

How 1 sources are covering this

New study supports testing of Merck’s Ebola vaccine in DRC outbreak

More from Health

STAT+: What is a ‘world model’? Nabla’s Alex LeBrun explains

African countries are facing rising rates of cancer. What's being done about it?

A strange transmissible cancer is spreading through the catfish in this lake

In pursuit of 'Instagram face,' are we losing the imperfections that make us human?

Reader

Trust & legal

Across the network

How 1 sources are covering this

New study supports testing of Merck’s Ebola vaccine in DRC outbreak

More from Health

STAT+: What is a ‘world model’? Nabla&#8217;s Alex LeBrun explains

African countries are facing rising rates of cancer. What's being done about it?

A strange transmissible cancer is spreading through the catfish in this lake

In pursuit of 'Instagram face,' are we losing the imperfections that make us human?

Reader

Trust & legal

Across the network

STAT+: What is a ‘world model’? Nabla’s Alex LeBrun explains